Inhibitory Effect of Berbamine on Proliferation of UMR-106 Rat Osteosarcoma Cells
Renjie Hu
Abstract
Renjie Hu
Abstract
Objective: To explore the inhibitory effect of berbamine on the proliferation of UMR-106 rat osteosarcoma cells and its possible mechanism in vitro. Methods: UMR-106 cells were cultured with different concentrations of berbamine (0, 2, 4, 8, 16 and 32 mg/L) for 24, 48 and 72 h, respectively. The proliferation was colorimetrically assayed by MTT. UMR-106 cells were interfered with different concentrations of berbamine (0, 4, 8 and 16 mg/L) for 24 h, and the morphological changes of UMR-106 cells were observed by laser confocal scan microscope after Hoechst 33258 staining. The apoptotic rates were detected by flow cytometry (FCM)using Annexin V/PI staining. The cell cycle was detected by FCM using PI staining. Results: Berbamine could obviously inhibit the proliferation of UMR-106 cells in a dose-dependent manner (P 0.01). The IC50 values at 24, 48 and 72 h were 24.69, 8.03 and 3.54 mg/L, respectively. There were nuclear condensation and apoptotic body in berbamine treated group. Apoptotic rates were (1.64±0.29)%,(3.58±0.31)%,(6.27±0.47)% and (11.27±1.09)% in control group and berbamine treated group (after 4, 8 and 16 mg/L treatment),respectively. There was a significant difference in apoptotic rate between berbamine treated group and control group (P 0.01). Meanwhile, berbamine can induce cell necrosis. In addition, berbamine significantly increased the percentages of G0/G1 phase and decreased S phase of cells and G2/M phase compared with those of control group (P 0.01). Conclusion: Berbamine can inhibit the proliferation of UMR-106 cells in vitro, which may be related to the cell apoptosis, necrosis and G0/G1 phase arrest.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective: To explore the inhibitory effect of berbamine on the proliferation of UMR-106 rat osteosarcoma cells and its possible mechanism in vitro. Methods: UMR-106 cells were cultured with different concentrations of berbamine (0, 2, 4, 8, 16 and 32 mg/L) for 24, 48 and 72 h, respectively. The proliferation was colorimetrically assayed by MTT. UMR-106 cells were interfered with different concentrations of berbamine (0, 4, 8 and 16 mg/L) for 24 h, and the morphological changes of UMR-106 cells were observed by laser confocal scan microscope after Hoechst 33258 staining. The apoptotic rates were detected by flow cytometry (FCM)using Annexin V/PI staining. The cell cycle was detected by FCM using PI staining. Results: Berbamine could obviously inhibit the proliferation of UMR-106 cells in a dose-dependent manner (P 0.01). The IC50 values at 24, 48 and 72 h were 24.69, 8.03 and 3.54 mg/L, respectively. There were nuclear condensation and apoptotic body in berbamine treated group. Apoptotic rates were (1.64±0.29)%,(3.58±0.31)%,(6.27±0.47)% and (11.27±1.09)% in control group and berbamine treated group (after 4, 8 and 16 mg/L treatment),respectively. There was a significant difference in apoptotic rate between berbamine treated group and control group (P 0.01). Meanwhile, berbamine can induce cell necrosis. In addition, berbamine significantly increased the percentages of G0/G1 phase and decreased S phase of cells and G2/M phase compared with those of control group (P 0.01). Conclusion: Berbamine can inhibit the proliferation of UMR-106 cells in vitro, which may be related to the cell apoptosis, necrosis and G0/G1 phase arrest.
Key concepts: Apoptosis, Cell cycle, Cell growth, Flow cytometry, Staining, Molecular biology, Chemistry, Annexin